Ecofibre Limited, together with its subsidiaries, engages in the breeding, growing, manufacturing, marketing, and selling hemp products in the United States and Australia.
No risks detected for EOF from our risk checks.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.82|
|52 Week High||AU$0.47|
|52 Week Low||AU$2.32|
|1 Month Change||-2.37%|
|3 Month Change||3.13%|
|1 Year Change||-54.42%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-51.47%|
Recent News & Updates
One Forecaster Is Now More Bearish On Ecofibre Limited (ASX:EOF) Than They Used To Be
Market forces rained on the parade of Ecofibre Limited ( ASX:EOF ) shareholders today, when the covering analyst...
Ecofibre (ASX:EOF) Has Debt But No Earnings; Should You Worry?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Would Shareholders Who Purchased Ecofibre's (ASX:EOF) Stock Year Be Happy With The Share price Today?
The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...
|EOF||AU Pharmaceuticals||AU Market|
Return vs Industry: EOF underperformed the Australian Pharmaceuticals industry which returned -2.4% over the past year.
Return vs Market: EOF underperformed the Australian Market which returned 20.2% over the past year.
Stable Share Price: EOF is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: EOF's weekly volatility (10%) has been stable over the past year.
About the Company
Ecofibre Limited, together with its subsidiaries, engages in the breeding, growing, manufacturing, marketing, and selling hemp products in the United States and Australia. The company operates through Ananda Health, Ananda Food, and Hemp Black segments. It offers nutraceutical products for human and pet consumption, as well as topical creams and salves; CBD products; grows and produces hemp food products, including protein powders, de-hulled hemp seed, and hemp oil; and develops and produces hemp-based textile products.
Ecofibre Fundamentals Summary
|EOF fundamental statistics|
Is EOF overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EOF income statement (TTM)|
|Cost of Revenue||AU$12.06m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.021|
|Net Profit Margin||-24.26%|
How did EOF perform over the long term?See historical performance and comparison
Is Ecofibre undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate EOF's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate EOF's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: EOF is unprofitable, so we can't compare its PE Ratio to the Oceanic Pharmaceuticals industry average.
PE vs Market: EOF is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EOF's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EOF is good value based on its PB Ratio (2.4x) compared to the AU Pharmaceuticals industry average (3.3x).
How is Ecofibre forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ecofibre has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Ecofibre performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EOF is currently unprofitable.
Growing Profit Margin: EOF is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EOF is unprofitable, but has reduced losses over the past 5 years at a rate of 39.1% per year.
Accelerating Growth: Unable to compare EOF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EOF is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.4%).
Return on Equity
High ROE: EOF has a negative Return on Equity (-6.25%), as it is currently unprofitable.
How is Ecofibre's financial position?
Financial Position Analysis
Short Term Liabilities: EOF's short term assets (A$39.2M) exceed its short term liabilities (A$5.7M).
Long Term Liabilities: EOF's short term assets (A$39.2M) exceed its long term liabilities (A$24.2M).
Debt to Equity History and Analysis
Debt Level: EOF's debt to equity ratio (9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if EOF's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: EOF's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if EOF's interest payments on its debt are well covered by EBIT.
What is Ecofibre current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EOF's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EOF's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EOF's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EOF's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EOF's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Eric Wang has been Chief Executive Officer and Managing Director of Ecofibre Limited since December 2017 and has been its Director since December 2015. Mr. Wang has leadership and executive management...
CEO Compensation Analysis
Compensation vs Market: Eric's total compensation ($USD804.65K) is above average for companies of similar size in the Australian market ($USD556.28K).
Compensation vs Earnings: Eric's compensation has been consistent with company performance over the past year.
Experienced Management: EOF's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Experienced Board: EOF's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Ecofibre Limited's employee growth, exchange listings and data sources
- Name: Ecofibre Limited
- Ticker: EOF
- Exchange: ASX
- Founded: 2009
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: AU$269.525m
- Shares outstanding: 326.70m
- Website: https://www.ecofibre.com
- Ecofibre Limited
- 680 George Street
- Level 12
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/18 15:39|
|End of Day Share Price||2021/10/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.